<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1413">
  <stage>Registered</stage>
  <submitdate>22/06/2006</submitdate>
  <approvaldate>29/06/2006</approvaldate>
  <actrnumber>ACTRN12606000271505</actrnumber>
  <trial_identification>
    <studytitle>A randomized controlled trial using exercise to reduce gestational diabetes and other adverse maternal and neonatal outcomes in obese pregnant women The pilot study.</studytitle>
    <scientifictitle>A randomized controlled trial using exercise to reduce gestational diabetes and other adverse maternal and neonatal outcomes in obese pregnant women The pilot study.</scientifictitle>
    <utrn />
    <trialacronym>BAMBINO Study-Becoming Active Mothers for Better Infant Outcomes</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Obese Pregnant Women</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Other reproductive health and childbirth disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Flexible exercise program with a goal of 1500 kCal of energy expenditure per week (approximately equivalent to 30 minutes of activity 5 days per week), measured using exercise diary, heart rate monitor and accelerometer data.  The flexible individually tailored exercise program will be developed and reviewed weekly by exercise physiologists.  Exercise will be commenced prior to 12 weeks gestation and will continue until delivery or development of a contraindication to exercise. </interventions>
    <comparator>The control group will be assigned to usual activity.</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Increased physical activity</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Fasting glucose, insulin, Fitness, body composition, resting blood pressure, inflammatory markers and
quality of life.</outcome>
      <timepoint>Measured at baseline, 20 weeks gestation, 28 weeks gestation, 36 weeks gestation and 6 weeks postpartum.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Neonatal body composition</outcome>
      <timepoint>Assessed at delivery and at 6 weeks post partum.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Pregnant, less than 12 weeks gestationBMI 30 or greater. Willing and able to be randomized to an exercise intervention. Able to provide informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindication or inability to exercise.Not able to speak English.Medical or obstetric contraindication to exercise including haemodynamically significant heart disease, restrictive lung disease, incompetent cervix (cerclage), multiple gestation, severe anaemia, chronic bronchitis, type 1 diabetes, orthopaedic limitations, poorly controlled seizure disorder, poorly controlled hyperthyroidism, heavy smoker [ACOG guidelines].</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation involves contacting an independent administrator who holds the allocation schedule.</concealment>
    <sequence>An independent statistician will manage sequence generation, using a computer generated random number sequence.  Women will be stratified by 1.BMI 30-40 vs BMI&gt;40 and 2.  Children at home vs No children at home.  Women within each strata will be randomly allocated to the control vs intervention group.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>24/07/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Brisbane and Women's Hospital (RBWH) Foundation</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Brisbane and Women's Hospital (RBWH) Foundation Grant</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a pilot study to look at the feasibility of a target directed flexible exercise program in obese pregnant women.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane and Women's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>16/06/2006</ethicapprovaldate>
      <hrec>2006/076</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of QLD</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>QLD University of Technology</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Leonie Callaway</name>
      <address>E Floor
Clinical Sciences Building
Royal Brisbane and Womens Hospital
HERSTON  QLD  4054</address>
      <phone>07 3346 4917  or page via RBWH switch (07 3636 8111)</phone>
      <fax>07 3346 4734</fax>
      <email>lcallaway@somc.uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Katie Foxcroft</name>
      <address>Royal Brisbane and Women's Hospital
Butterfield St 
Herston,Qld 4029</address>
      <phone>07 36365164</phone>
      <fax>07 36365737</fax>
      <email>katie_foxcroft@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>